0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Non-Drug-Eluting Devices Market Research Report 2024
Published Date: October 2024
|
Report Code: QYRE-Auto-11D18647
Home | Market Reports | Health| Medical Devices & Equipment
Global Non Drug Eluting Devices Market Research Report 2024
BUY CHAPTERS

Global Non-Drug-Eluting Devices Market Research Report 2024

Code: QYRE-Auto-11D18647
Report
October 2024
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Non-Drug-Eluting Devices Market

Non-drug eluting devices perform specific functions without releasing drugs. They are used in medical procedures and treatments, focusing on physical or mechanical interventions. Implants typically need removal, while sutures dissolve naturally and do not require removal. Key properties of these devices include primarily providing structural support, being made from biocompatible materials, maintaining sterility to prevent infections, offering high durability and strength, and performing specific functions. Long-term use of drugs to treat cardiovascular diseases may cause some side effects, such as bleeding, liver and kidney damage, etc. Non-drug eluting devices can reduce the amount of drugs used to a certain extent, thereby reducing the risk of drug side effects. With the continuous advancement of medical imaging technology and interventional treatment technology, the treatment of non-drug eluting devices will be more accurate. Doctors can use high-resolution imaging equipment to accurately locate the lesion and select appropriate treatment methods and equipment to improve the treatment effect.
The global Non-Drug-Eluting Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Non-Drug-Eluting Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Non-Drug-Eluting Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Non-Drug-Eluting Devices include Stryker Corporation, Medtronic, B. Braun Melsungen AG, Boston Scientific Corporation, ConMed Corporation, DemeTECH Corporation, Integra Lifesciences, Johnson & Johnson, Peter Surgical, Smith & Nephew plc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Non-Drug-Eluting Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Drug-Eluting Devices.
The Non-Drug-Eluting Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Non-Drug-Eluting Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non-Drug-Eluting Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Non-Drug-Eluting Devices Market Report

Report Metric Details
Report Name Non-Drug-Eluting Devices Market
Segment by Type
  • Implants
  • Sutures
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Stryker Corporation, Medtronic, B. Braun Melsungen AG, Boston Scientific Corporation, ConMed Corporation, DemeTECH Corporation, Integra Lifesciences, Johnson & Johnson, Peter Surgical, Smith & Nephew plc., Teleflex Incorporated
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Non-Drug-Eluting Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Non-Drug-Eluting Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Non-Drug-Eluting Devices Market report?

Ans: The main players in the Non-Drug-Eluting Devices Market are Stryker Corporation, Medtronic, B. Braun Melsungen AG, Boston Scientific Corporation, ConMed Corporation, DemeTECH Corporation, Integra Lifesciences, Johnson & Johnson, Peter Surgical, Smith & Nephew plc., Teleflex Incorporated

What are the Application segmentation covered in the Non-Drug-Eluting Devices Market report?

Ans: The Applications covered in the Non-Drug-Eluting Devices Market report are Hospital, Ambulatory Surgical Centers

What are the Type segmentation covered in the Non-Drug-Eluting Devices Market report?

Ans: The Types covered in the Non-Drug-Eluting Devices Market report are Implants, Sutures

Recommended Reports

Non-Drug Devices

Cardiovascular & Vascular

Surgical Accessories

1 Non-Drug-Eluting Devices Market Overview
1.1 Product Definition
1.2 Non-Drug-Eluting Devices by Type
1.2.1 Global Non-Drug-Eluting Devices Market Value Comparison by Type (2024-2030)
1.2.2 Implants
1.2.3 Sutures
1.3 Non-Drug-Eluting Devices by Application
1.3.1 Global Non-Drug-Eluting Devices Market Value by Application (2024-2030)
1.3.2 Hospital
1.3.3 Ambulatory Surgical Centers
1.4 Global Non-Drug-Eluting Devices Market Size Estimates and Forecasts
1.4.1 Global Non-Drug-Eluting Devices Revenue 2019-2030
1.4.2 Global Non-Drug-Eluting Devices Sales 2019-2030
1.4.3 Global Non-Drug-Eluting Devices Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Non-Drug-Eluting Devices Market Competition by Manufacturers
2.1 Global Non-Drug-Eluting Devices Sales Market Share by Manufacturers (2019-2024)
2.2 Global Non-Drug-Eluting Devices Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Non-Drug-Eluting Devices Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Non-Drug-Eluting Devices, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Non-Drug-Eluting Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Non-Drug-Eluting Devices, Product Type & Application
2.7 Global Key Manufacturers of Non-Drug-Eluting Devices, Date of Enter into This Industry
2.8 Global Non-Drug-Eluting Devices Market Competitive Situation and Trends
2.8.1 Global Non-Drug-Eluting Devices Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Non-Drug-Eluting Devices Players Market Share by Revenue
2.8.3 Global Non-Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Non-Drug-Eluting Devices Market Scenario by Region
3.1 Global Non-Drug-Eluting Devices Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Non-Drug-Eluting Devices Sales by Region: 2019-2030
3.2.1 Global Non-Drug-Eluting Devices Sales by Region: 2019-2024
3.2.2 Global Non-Drug-Eluting Devices Sales by Region: 2025-2030
3.3 Global Non-Drug-Eluting Devices Revenue by Region: 2019-2030
3.3.1 Global Non-Drug-Eluting Devices Revenue by Region: 2019-2024
3.3.2 Global Non-Drug-Eluting Devices Revenue by Region: 2025-2030
3.4 North America Non-Drug-Eluting Devices Market Facts & Figures by Country
3.4.1 North America Non-Drug-Eluting Devices Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Non-Drug-Eluting Devices Sales by Country (2019-2030)
3.4.3 North America Non-Drug-Eluting Devices Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Non-Drug-Eluting Devices Market Facts & Figures by Country
3.5.1 Europe Non-Drug-Eluting Devices Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Non-Drug-Eluting Devices Sales by Country (2019-2030)
3.5.3 Europe Non-Drug-Eluting Devices Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Non-Drug-Eluting Devices Market Facts & Figures by Region
3.6.1 Asia Pacific Non-Drug-Eluting Devices Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Non-Drug-Eluting Devices Sales by Region (2019-2030)
3.6.3 Asia Pacific Non-Drug-Eluting Devices Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Non-Drug-Eluting Devices Market Facts & Figures by Country
3.7.1 Latin America Non-Drug-Eluting Devices Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Non-Drug-Eluting Devices Sales by Country (2019-2030)
3.7.3 Latin America Non-Drug-Eluting Devices Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Non-Drug-Eluting Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Non-Drug-Eluting Devices Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Non-Drug-Eluting Devices Sales by Country (2019-2030)
3.8.3 Middle East and Africa Non-Drug-Eluting Devices Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Non-Drug-Eluting Devices Sales by Type (2019-2030)
4.1.1 Global Non-Drug-Eluting Devices Sales by Type (2019-2024)
4.1.2 Global Non-Drug-Eluting Devices Sales by Type (2025-2030)
4.1.3 Global Non-Drug-Eluting Devices Sales Market Share by Type (2019-2030)
4.2 Global Non-Drug-Eluting Devices Revenue by Type (2019-2030)
4.2.1 Global Non-Drug-Eluting Devices Revenue by Type (2019-2024)
4.2.2 Global Non-Drug-Eluting Devices Revenue by Type (2025-2030)
4.2.3 Global Non-Drug-Eluting Devices Revenue Market Share by Type (2019-2030)
4.3 Global Non-Drug-Eluting Devices Price by Type (2019-2030)
5 Segment by Application
5.1 Global Non-Drug-Eluting Devices Sales by Application (2019-2030)
5.1.1 Global Non-Drug-Eluting Devices Sales by Application (2019-2024)
5.1.2 Global Non-Drug-Eluting Devices Sales by Application (2025-2030)
5.1.3 Global Non-Drug-Eluting Devices Sales Market Share by Application (2019-2030)
5.2 Global Non-Drug-Eluting Devices Revenue by Application (2019-2030)
5.2.1 Global Non-Drug-Eluting Devices Revenue by Application (2019-2024)
5.2.2 Global Non-Drug-Eluting Devices Revenue by Application (2025-2030)
5.2.3 Global Non-Drug-Eluting Devices Revenue Market Share by Application (2019-2030)
5.3 Global Non-Drug-Eluting Devices Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Stryker Corporation
6.1.1 Stryker Corporation Company Information
6.1.2 Stryker Corporation Description and Business Overview
6.1.3 Stryker Corporation Non-Drug-Eluting Devices Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Stryker Corporation Non-Drug-Eluting Devices Product Portfolio
6.1.5 Stryker Corporation Recent Developments/Updates
6.2 Medtronic
6.2.1 Medtronic Company Information
6.2.2 Medtronic Description and Business Overview
6.2.3 Medtronic Non-Drug-Eluting Devices Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Medtronic Non-Drug-Eluting Devices Product Portfolio
6.2.5 Medtronic Recent Developments/Updates
6.3 B. Braun Melsungen AG
6.3.1 B. Braun Melsungen AG Company Information
6.3.2 B. Braun Melsungen AG Description and Business Overview
6.3.3 B. Braun Melsungen AG Non-Drug-Eluting Devices Sales, Revenue and Gross Margin (2019-2024)
6.3.4 B. Braun Melsungen AG Non-Drug-Eluting Devices Product Portfolio
6.3.5 B. Braun Melsungen AG Recent Developments/Updates
6.4 Boston Scientific Corporation
6.4.1 Boston Scientific Corporation Company Information
6.4.2 Boston Scientific Corporation Description and Business Overview
6.4.3 Boston Scientific Corporation Non-Drug-Eluting Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Boston Scientific Corporation Non-Drug-Eluting Devices Product Portfolio
6.4.5 Boston Scientific Corporation Recent Developments/Updates
6.5 ConMed Corporation
6.5.1 ConMed Corporation Company Information
6.5.2 ConMed Corporation Description and Business Overview
6.5.3 ConMed Corporation Non-Drug-Eluting Devices Sales, Revenue and Gross Margin (2019-2024)
6.5.4 ConMed Corporation Non-Drug-Eluting Devices Product Portfolio
6.5.5 ConMed Corporation Recent Developments/Updates
6.6 DemeTECH Corporation
6.6.1 DemeTECH Corporation Company Information
6.6.2 DemeTECH Corporation Description and Business Overview
6.6.3 DemeTECH Corporation Non-Drug-Eluting Devices Sales, Revenue and Gross Margin (2019-2024)
6.6.4 DemeTECH Corporation Non-Drug-Eluting Devices Product Portfolio
6.6.5 DemeTECH Corporation Recent Developments/Updates
6.7 Integra Lifesciences
6.7.1 Integra Lifesciences Company Information
6.7.2 Integra Lifesciences Description and Business Overview
6.7.3 Integra Lifesciences Non-Drug-Eluting Devices Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Integra Lifesciences Non-Drug-Eluting Devices Product Portfolio
6.7.5 Integra Lifesciences Recent Developments/Updates
6.8 Johnson & Johnson
6.8.1 Johnson & Johnson Company Information
6.8.2 Johnson & Johnson Description and Business Overview
6.8.3 Johnson & Johnson Non-Drug-Eluting Devices Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Johnson & Johnson Non-Drug-Eluting Devices Product Portfolio
6.8.5 Johnson & Johnson Recent Developments/Updates
6.9 Peter Surgical
6.9.1 Peter Surgical Company Information
6.9.2 Peter Surgical Description and Business Overview
6.9.3 Peter Surgical Non-Drug-Eluting Devices Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Peter Surgical Non-Drug-Eluting Devices Product Portfolio
6.9.5 Peter Surgical Recent Developments/Updates
6.10 Smith & Nephew plc.
6.10.1 Smith & Nephew plc. Company Information
6.10.2 Smith & Nephew plc. Description and Business Overview
6.10.3 Smith & Nephew plc. Non-Drug-Eluting Devices Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Smith & Nephew plc. Non-Drug-Eluting Devices Product Portfolio
6.10.5 Smith & Nephew plc. Recent Developments/Updates
6.11 Teleflex Incorporated
6.11.1 Teleflex Incorporated Company Information
6.11.2 Teleflex Incorporated Description and Business Overview
6.11.3 Teleflex Incorporated Non-Drug-Eluting Devices Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Teleflex Incorporated Non-Drug-Eluting Devices Product Portfolio
6.11.5 Teleflex Incorporated Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Non-Drug-Eluting Devices Industry Chain Analysis
7.2 Non-Drug-Eluting Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Non-Drug-Eluting Devices Production Mode & Process
7.4 Non-Drug-Eluting Devices Sales and Marketing
7.4.1 Non-Drug-Eluting Devices Sales Channels
7.4.2 Non-Drug-Eluting Devices Distributors
7.5 Non-Drug-Eluting Devices Customers
8 Non-Drug-Eluting Devices Market Dynamics
8.1 Non-Drug-Eluting Devices Industry Trends
8.2 Non-Drug-Eluting Devices Market Drivers
8.3 Non-Drug-Eluting Devices Market Challenges
8.4 Non-Drug-Eluting Devices Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Non-Drug-Eluting Devices Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Non-Drug-Eluting Devices Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Non-Drug-Eluting Devices Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Non-Drug-Eluting Devices Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Non-Drug-Eluting Devices Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Non-Drug-Eluting Devices Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Non-Drug-Eluting Devices Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Non-Drug-Eluting Devices Average Price (K US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Non-Drug-Eluting Devices, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Non-Drug-Eluting Devices, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Non-Drug-Eluting Devices, Product Type & Application
 Table 12. Global Key Manufacturers of Non-Drug-Eluting Devices, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Non-Drug-Eluting Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Drug-Eluting Devices as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Non-Drug-Eluting Devices Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Non-Drug-Eluting Devices Sales by Region (2019-2024) & (K Units)
 Table 18. Global Non-Drug-Eluting Devices Sales Market Share by Region (2019-2024)
 Table 19. Global Non-Drug-Eluting Devices Sales by Region (2025-2030) & (K Units)
 Table 20. Global Non-Drug-Eluting Devices Sales Market Share by Region (2025-2030)
 Table 21. Global Non-Drug-Eluting Devices Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Non-Drug-Eluting Devices Revenue Market Share by Region (2019-2024)
 Table 23. Global Non-Drug-Eluting Devices Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Non-Drug-Eluting Devices Revenue Market Share by Region (2025-2030)
 Table 25. North America Non-Drug-Eluting Devices Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Non-Drug-Eluting Devices Sales by Country (2019-2024) & (K Units)
 Table 27. North America Non-Drug-Eluting Devices Sales by Country (2025-2030) & (K Units)
 Table 28. North America Non-Drug-Eluting Devices Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Non-Drug-Eluting Devices Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Non-Drug-Eluting Devices Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Non-Drug-Eluting Devices Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Non-Drug-Eluting Devices Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Non-Drug-Eluting Devices Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Non-Drug-Eluting Devices Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Non-Drug-Eluting Devices Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Non-Drug-Eluting Devices Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Non-Drug-Eluting Devices Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Non-Drug-Eluting Devices Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Non-Drug-Eluting Devices Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Non-Drug-Eluting Devices Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Non-Drug-Eluting Devices Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Non-Drug-Eluting Devices Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Non-Drug-Eluting Devices Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Non-Drug-Eluting Devices Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Non-Drug-Eluting Devices Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Non-Drug-Eluting Devices Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Non-Drug-Eluting Devices Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Non-Drug-Eluting Devices Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Non-Drug-Eluting Devices Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Non-Drug-Eluting Devices Sales (K Units) by Type (2019-2024)
 Table 51. Global Non-Drug-Eluting Devices Sales (K Units) by Type (2025-2030)
 Table 52. Global Non-Drug-Eluting Devices Sales Market Share by Type (2019-2024)
 Table 53. Global Non-Drug-Eluting Devices Sales Market Share by Type (2025-2030)
 Table 54. Global Non-Drug-Eluting Devices Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Non-Drug-Eluting Devices Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Non-Drug-Eluting Devices Revenue Market Share by Type (2019-2024)
 Table 57. Global Non-Drug-Eluting Devices Revenue Market Share by Type (2025-2030)
 Table 58. Global Non-Drug-Eluting Devices Price (K US$/Unit) by Type (2019-2024)
 Table 59. Global Non-Drug-Eluting Devices Price (K US$/Unit) by Type (2025-2030)
 Table 60. Global Non-Drug-Eluting Devices Sales (K Units) by Application (2019-2024)
 Table 61. Global Non-Drug-Eluting Devices Sales (K Units) by Application (2025-2030)
 Table 62. Global Non-Drug-Eluting Devices Sales Market Share by Application (2019-2024)
 Table 63. Global Non-Drug-Eluting Devices Sales Market Share by Application (2025-2030)
 Table 64. Global Non-Drug-Eluting Devices Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Non-Drug-Eluting Devices Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Non-Drug-Eluting Devices Revenue Market Share by Application (2019-2024)
 Table 67. Global Non-Drug-Eluting Devices Revenue Market Share by Application (2025-2030)
 Table 68. Global Non-Drug-Eluting Devices Price (K US$/Unit) by Application (2019-2024)
 Table 69. Global Non-Drug-Eluting Devices Price (K US$/Unit) by Application (2025-2030)
 Table 70. Stryker Corporation Company Information
 Table 71. Stryker Corporation Description and Business Overview
 Table 72. Stryker Corporation Non-Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
 Table 73. Stryker Corporation Non-Drug-Eluting Devices Product
 Table 74. Stryker Corporation Recent Developments/Updates
 Table 75. Medtronic Company Information
 Table 76. Medtronic Description and Business Overview
 Table 77. Medtronic Non-Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
 Table 78. Medtronic Non-Drug-Eluting Devices Product
 Table 79. Medtronic Recent Developments/Updates
 Table 80. B. Braun Melsungen AG Company Information
 Table 81. B. Braun Melsungen AG Description and Business Overview
 Table 82. B. Braun Melsungen AG Non-Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
 Table 83. B. Braun Melsungen AG Non-Drug-Eluting Devices Product
 Table 84. B. Braun Melsungen AG Recent Developments/Updates
 Table 85. Boston Scientific Corporation Company Information
 Table 86. Boston Scientific Corporation Description and Business Overview
 Table 87. Boston Scientific Corporation Non-Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
 Table 88. Boston Scientific Corporation Non-Drug-Eluting Devices Product
 Table 89. Boston Scientific Corporation Recent Developments/Updates
 Table 90. ConMed Corporation Company Information
 Table 91. ConMed Corporation Description and Business Overview
 Table 92. ConMed Corporation Non-Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
 Table 93. ConMed Corporation Non-Drug-Eluting Devices Product
 Table 94. ConMed Corporation Recent Developments/Updates
 Table 95. DemeTECH Corporation Company Information
 Table 96. DemeTECH Corporation Description and Business Overview
 Table 97. DemeTECH Corporation Non-Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
 Table 98. DemeTECH Corporation Non-Drug-Eluting Devices Product
 Table 99. DemeTECH Corporation Recent Developments/Updates
 Table 100. Integra Lifesciences Company Information
 Table 101. Integra Lifesciences Description and Business Overview
 Table 102. Integra Lifesciences Non-Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
 Table 103. Integra Lifesciences Non-Drug-Eluting Devices Product
 Table 104. Integra Lifesciences Recent Developments/Updates
 Table 105. Johnson & Johnson Company Information
 Table 106. Johnson & Johnson Description and Business Overview
 Table 107. Johnson & Johnson Non-Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
 Table 108. Johnson & Johnson Non-Drug-Eluting Devices Product
 Table 109. Johnson & Johnson Recent Developments/Updates
 Table 110. Peter Surgical Company Information
 Table 111. Peter Surgical Description and Business Overview
 Table 112. Peter Surgical Non-Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
 Table 113. Peter Surgical Non-Drug-Eluting Devices Product
 Table 114. Peter Surgical Recent Developments/Updates
 Table 115. Smith & Nephew plc. Company Information
 Table 116. Smith & Nephew plc. Description and Business Overview
 Table 117. Smith & Nephew plc. Non-Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
 Table 118. Smith & Nephew plc. Non-Drug-Eluting Devices Product
 Table 119. Smith & Nephew plc. Recent Developments/Updates
 Table 120. Teleflex Incorporated Company Information
 Table 121. Teleflex Incorporated Description and Business Overview
 Table 122. Teleflex Incorporated Non-Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
 Table 123. Teleflex Incorporated Non-Drug-Eluting Devices Product
 Table 124. Teleflex Incorporated Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Non-Drug-Eluting Devices Distributors List
 Table 128. Non-Drug-Eluting Devices Customers List
 Table 129. Non-Drug-Eluting Devices Market Trends
 Table 130. Non-Drug-Eluting Devices Market Drivers
 Table 131. Non-Drug-Eluting Devices Market Challenges
 Table 132. Non-Drug-Eluting Devices Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Non-Drug-Eluting Devices
 Figure 2. Global Non-Drug-Eluting Devices Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Non-Drug-Eluting Devices Market Share by Type: 2023 & 2030
 Figure 4. Implants Product Picture
 Figure 5. Sutures Product Picture
 Figure 6. Global Non-Drug-Eluting Devices Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global Non-Drug-Eluting Devices Market Share by Application: 2023 & 2030
 Figure 8. Hospital
 Figure 9. Ambulatory Surgical Centers
 Figure 10. Global Non-Drug-Eluting Devices Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 11. Global Non-Drug-Eluting Devices Market Size (2019-2030) & (US$ Million)
 Figure 12. Global Non-Drug-Eluting Devices Sales (2019-2030) & (K Units)
 Figure 13. Global Non-Drug-Eluting Devices Average Price (K US$/Unit) & (2019-2030)
 Figure 14. Non-Drug-Eluting Devices Report Years Considered
 Figure 15. Non-Drug-Eluting Devices Sales Share by Manufacturers in 2023
 Figure 16. Global Non-Drug-Eluting Devices Revenue Share by Manufacturers in 2023
 Figure 17. Global 5 and 10 Largest Non-Drug-Eluting Devices Players: Market Share by Revenue in Non-Drug-Eluting Devices in 2023
 Figure 18. Non-Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 19. Global Non-Drug-Eluting Devices Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 20. North America Non-Drug-Eluting Devices Sales Market Share by Country (2019-2030)
 Figure 21. North America Non-Drug-Eluting Devices Revenue Market Share by Country (2019-2030)
 Figure 22. United States Non-Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 23. Canada Non-Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 24. Europe Non-Drug-Eluting Devices Sales Market Share by Country (2019-2030)
 Figure 25. Europe Non-Drug-Eluting Devices Revenue Market Share by Country (2019-2030)
 Figure 26. Germany Non-Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 27. France Non-Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. U.K. Non-Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. Italy Non-Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Russia Non-Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Asia Pacific Non-Drug-Eluting Devices Sales Market Share by Region (2019-2030)
 Figure 32. Asia Pacific Non-Drug-Eluting Devices Revenue Market Share by Region (2019-2030)
 Figure 33. China Non-Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Japan Non-Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. South Korea Non-Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. India Non-Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. Australia Non-Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. China Taiwan Non-Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Southeast Asia Non-Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Latin America Non-Drug-Eluting Devices Sales Market Share by Country (2019-2030)
 Figure 41. Mexico Non-Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Brazil Non-Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Argentina Non-Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Colombia Non-Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Middle East and Africa Non-Drug-Eluting Devices Sales Market Share by Country (2019-2030)
 Figure 46. Middle East and Africa Non-Drug-Eluting Devices Revenue Market Share by Country (2019-2030)
 Figure 47. Turkey Non-Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Saudi Arabia Non-Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. UAE Non-Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Global Sales Market Share of Non-Drug-Eluting Devices by Type (2019-2030)
 Figure 51. Global Revenue Market Share of Non-Drug-Eluting Devices by Type (2019-2030)
 Figure 52. Global Non-Drug-Eluting Devices Price (K US$/Unit) by Type (2019-2030)
 Figure 53. Global Sales Market Share of Non-Drug-Eluting Devices by Application (2019-2030)
 Figure 54. Global Revenue Market Share of Non-Drug-Eluting Devices by Application (2019-2030)
 Figure 55. Global Non-Drug-Eluting Devices Price (K US$/Unit) by Application (2019-2030)
 Figure 56. Non-Drug-Eluting Devices Value Chain
 Figure 57. Non-Drug-Eluting Devices Production Process
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

RELATED REPORTS

Global Surgical Waste Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16G6108
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global PET-CT Scanning Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27Q5892
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Micromanipulation Pipettes for IVF Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14K19926
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Nebulizer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15N17310
Fri Sep 12 00:00:00 UTC 2025

Add to Cart